PCN160 Potential Impact of Advanced Therapy Medicinal Products on Irish Hematology-Oncology Care Pathway

Abstract

Authors

A. Maher M. Mc Alister J. Gallagher

Full Text Cite This Article
Back to Volume 24, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×